Tezspire
Drug timelines are a Plus or Pro feature.
26 regulatory and trial events tracked for Tezspire, covering 2021-12-17 to 2026-08-26. Get the full timeline:
Most recent: EMA Authorised: Tezspire (tezepelumab) — AstraZeneca AB
26 regulatory and trial events tracked for Tezspire, covering 2021-12-17 to 2026-08-26. Get the full timeline:
Most recent: EMA Authorised: Tezspire (tezepelumab) — AstraZeneca AB